After missing its self-imposed deadline of publishing the 340B administrative dispute resolution final rule by the end of 2023, the [...] …
Category: Providers
After implementing its first contract pharmacy restrictions in January, Japanese pharmaceutical giant Takeda recently subjected another drug to conditions on [...] …
A 340B hospital association this week asked a federal court to bar, without a full trial, federal regulators from reversing [...] …
Biopharmaceutical manufacturer Amgen recently expanded its conditions on 340B pricing at contract pharmacies to include grantees. The Thousand Oaks, California-based [...] …
Change Healthcare’s systems are down for a seventh straight day after it disconnected pharmacy services following a Feb. 21 cyberattack. [...] …
The New Hampshire state senate will vote next month on a bill to bar certain 340B-specific pharmacy benefit manager (PBM) [...] …
The Oregon state house is scheduled to vote today on a bill that would prohibit drugmaker 340B contract pharmacy restrictions [...] …
The highest-quality evidence from published 340B research indicates nonprofit, disproportionate share hospitals may be using the 340B program in margin-motivated [...] …
The drugmaker vendor 340B ESP’s recent requests for additional claims data from some 340B hospitals has raised concerns from 340B [...] …
Following the recent passage in the state house, the South Dakota Senate approved a bill earlier this week to bar [...] …